319 related articles for article (PubMed ID: 31932016)
1. Quantifying steatosis in the liver and pancreas with MRI in patient with chronic liver disease.
Vieira J; Amorim J; Martí-Bonmatí L; Alberich-Bayarri Á; França M
Radiologia (Engl Ed); 2020; 62(3):222-228. PubMed ID: 31932016
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of proton density fat fraction (PDFF) obtained from a vendor-neutral MRI sequence and MRQuantif software.
Orcel T; Chau HT; Turlin B; Chaigneau J; Bannier E; Otal P; Frampas E; Leguen A; Boulic A; Saint-Jalmes H; Aubé C; Boursier J; Bardou-Jacquet E; Gandon Y
Eur Radiol; 2023 Dec; 33(12):8999-9009. PubMed ID: 37402003
[TBL] [Abstract][Full Text] [Related]
3. Differences in multi-echo chemical shift encoded MRI proton density fat fraction estimation based on multifrequency fat peaks selection in non-alcoholic fatty liver disease patients.
Martí-Aguado D; Alberich-Bayarri Á; Martín-Rodríguez JL; França M; García-Castro F; González-Cantero J; González-Cantero Á; Martí-Bonmatí L
Clin Radiol; 2020 Nov; 75(11):880.e5-880.e12. PubMed ID: 32888653
[TBL] [Abstract][Full Text] [Related]
4. Can negligible hepatic steatosis determined by magnetic resonance imaging-proton density fat fraction obviate the need for liver biopsy in potential liver donors?
Satkunasingham J; Nik HH; Fischer S; Menezes R; Selzner N; Cattral M; Grant D; Jhaveri K
Liver Transpl; 2018 Apr; 24(4):470-477. PubMed ID: 29080242
[TBL] [Abstract][Full Text] [Related]
5. Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy.
Idilman IS; Aniktar H; Idilman R; Kabacam G; Savas B; Elhan A; Celik A; Bahar K; Karcaaltincaba M
Radiology; 2013 Jun; 267(3):767-75. PubMed ID: 23382293
[TBL] [Abstract][Full Text] [Related]
6. Accuracy of multi-echo Dixon sequence in quantification of hepatic steatosis in Chinese children and adolescents.
Zhao YZ; Gan YG; Zhou JL; Liu JQ; Cao WG; Cheng SM; Bai DM; Wang MZ; Gao FQ; Zhou SM
World J Gastroenterol; 2019 Mar; 25(12):1513-1523. PubMed ID: 30948914
[TBL] [Abstract][Full Text] [Related]
7. A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease.
Idilman IS; Keskin O; Celik A; Savas B; Elhan AH; Idilman R; Karcaaltincaba M
Acta Radiol; 2016 Mar; 57(3):271-8. PubMed ID: 25855666
[TBL] [Abstract][Full Text] [Related]
8. Agreement Between Magnetic Resonance Imaging Proton Density Fat Fraction Measurements and Pathologist-Assigned Steatosis Grades of Liver Biopsies From Adults With Nonalcoholic Steatohepatitis.
Middleton MS; Heba ER; Hooker CA; Bashir MR; Fowler KJ; Sandrasegaran K; Brunt EM; Kleiner DE; Doo E; Van Natta ML; Lavine JE; Neuschwander-Tetri BA; Sanyal A; Loomba R; Sirlin CB;
Gastroenterology; 2017 Sep; 153(3):753-761. PubMed ID: 28624576
[TBL] [Abstract][Full Text] [Related]
9. Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLD.
Permutt Z; Le TA; Peterson MR; Seki E; Brenner DA; Sirlin C; Loomba R
Aliment Pharmacol Ther; 2012 Jul; 36(1):22-9. PubMed ID: 22554256
[TBL] [Abstract][Full Text] [Related]
10. iATT liver fat quantification for steatosis grading by referring to MRI proton density fat fraction: a multicenter study.
Hirooka M; Ogawa S; Koizumi Y; Yoshida Y; Goto T; Yasuda S; Yamahira M; Tamai T; Kuromatsu R; Matsuzaki T; Suehiro T; Kamada Y; Sumida Y; Hiasa Y; Toyoda H; Kumada T
J Gastroenterol; 2024 Jun; 59(6):504-514. PubMed ID: 38553657
[TBL] [Abstract][Full Text] [Related]
11. Reliability of ultrasound hepatorenal index and magnetic resonance imaging proton density fat fraction techniques in the diagnosis of hepatic steatosis, with magnetic resonance spectroscopy as the reference standard.
Tran BV; Ujita K; Taketomi-Takahashi A; Hirasawa H; Suto T; Tsushima Y
PLoS One; 2021; 16(8):e0255768. PubMed ID: 34383812
[TBL] [Abstract][Full Text] [Related]
12. Quantitative magnetic resonance imaging of hepatic steatosis: Validation in ex vivo human livers.
Bannas P; Kramer H; Hernando D; Agni R; Cunningham AM; Mandal R; Motosugi U; Sharma SD; Munoz del Rio A; Fernandez L; Reeder SB
Hepatology; 2015 Nov; 62(5):1444-55. PubMed ID: 26224591
[TBL] [Abstract][Full Text] [Related]
13. Utility of Attenuation Coefficient Measurement Using an Ultrasound-Guided Attenuation Parameter for Evaluation of Hepatic Steatosis: Comparison With MRI-Determined Proton Density Fat Fraction.
Tada T; Kumada T; Toyoda H; Kobayashi N; Sone Y; Oguri T; Kamiyama N
AJR Am J Roentgenol; 2019 Feb; 212(2):332-341. PubMed ID: 30476453
[TBL] [Abstract][Full Text] [Related]
14. Accurate simultaneous quantification of liver steatosis and iron overload in diffuse liver diseases with MRI.
França M; Alberich-Bayarri Á; Martí-Bonmatí L; Oliveira P; Costa FE; Porto G; Vizcaíno JR; Gonzalez JS; Ribeiro E; Oliveira J; Pessegueiro Miranda H
Abdom Radiol (NY); 2017 May; 42(5):1434-1443. PubMed ID: 28110367
[TBL] [Abstract][Full Text] [Related]
15. Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials.
Noureddin M; Lam J; Peterson MR; Middleton M; Hamilton G; Le TA; Bettencourt R; Changchien C; Brenner DA; Sirlin C; Loomba R
Hepatology; 2013 Dec; 58(6):1930-40. PubMed ID: 23696515
[TBL] [Abstract][Full Text] [Related]
16. Segmental quantification of hepatic lipid content based on volumetric MRI data in patients with suspected iron overload.
Wunderlich AP; Cario H; Kannengießer S; Grunau V; Götz M; Hüttner F; Backhus J; Beer M; Schmidt SA
Rofo; 2024 May; 196(5):463-470. PubMed ID: 38081191
[TBL] [Abstract][Full Text] [Related]
17. Automated Whole-Liver MRI Segmentation to Assess Steatosis and Iron Quantification in Chronic Liver Disease.
Martí-Aguado D; Jiménez-Pastor A; Alberich-Bayarri Á; Rodríguez-Ortega A; Alfaro-Cervello C; Mestre-Alagarda C; Bauza M; Gallén-Peris A; Valero-Pérez E; Ballester MP; Gimeno-Torres M; Pérez-Girbés A; Benlloch S; Pérez-Rojas J; Puglia V; Ferrández A; Aguilera V; Escudero-García D; Serra MA; Martí-Bonmatí L
Radiology; 2022 Feb; 302(2):345-354. PubMed ID: 34783592
[TBL] [Abstract][Full Text] [Related]
18. Assessment of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease by Using Quantitative US.
Han A; Zhang YN; Boehringer AS; Montes V; Andre MP; Erdman JW; Loomba R; Valasek MA; Sirlin CB; O'Brien WD
Radiology; 2020 Apr; 295(1):106-113. PubMed ID: 32013792
[TBL] [Abstract][Full Text] [Related]
19. Three-dimensional analysis of pancreatic fat by fat-water magnetic resonance imaging provides detailed characterization of pancreatic steatosis with improved reproducibility.
Kato S; Iwasaki A; Kurita Y; Arimoto J; Yamamoto T; Hasegawa S; Sato T; Imajo K; Hosono K; Kobayashi N; Yoneda M; Higurashi T; Kubota K; Utsunomiya D; Nakajima A
PLoS One; 2019; 14(12):e0224921. PubMed ID: 31790429
[TBL] [Abstract][Full Text] [Related]
20. Preoperative Evaluation of Pancreatic Fibrosis and Lipomatosis: Correlation of Magnetic Resonance Findings With Histology Using Magnetization Transfer Imaging and Multigradient Echo Magnetic Resonance Imaging.
Schawkat K; Eshmuminov D; Lenggenhager D; Endhardt K; Vrugt B; Boss A; Petrowsky H; Clavien PA; Reiner CS
Invest Radiol; 2018 Dec; 53(12):720-727. PubMed ID: 30247172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
